Dr. Tyler Sandow discusses three key strategies for mitigating lung shunts during Y90 radioembolization. He strongly advises against using low-dose Y90, noting its negative effect on cumulative lung dose. Dr. Sandow explains that patients with high lung shunts often have poor tumor biology and that early hepatic vein filling doesn’t always indicate a high shunt. He emphasizes the importance of confirming findings with MAA testing for accurate assessment and safer treatment planning. 🎧 Listen to